sixteen patients with hodgkin 's ( 10 ) and non-hodgkin 's ( 6 ) lymphoma were treated by the `` '' abcd scheme '' '' , which is a combination of adriamycin ( 25-30 mg/m2 day 1 ) , bleomycin ( 15 mg day 1-5 ) , ccnu ( 60 mg/m2 day 1 ) and dic ( 90-100 mg/m2 day 1-5 ) .
C0024305
non-hodgkin 's
C0005740
bleomyc